Saturday, December 31, 2016
Another great year of returns in 2016 even with overall biotech sector headwinds...Up 30%!!!!
I haven't posted much this year as I've been keeping very busy running my tech startup Record360 (www.record360.com) and chasing my 5 and 2 year old boys around the house but it's been another great year of returns for my Biotech Investments in 2016 with an average return between my three accounts of approximately 30%. Big winners include $ARRY, $EXEL, and $CPXX. Big losers include $CBIO, $INFI, and $OGXI.
I'm feeling pretty good about my portfolio going into 2017 and I plan to actively begin posting again when I buy and sell biotech stocks.
Happy Biotech Investing New Year in 2017!!!